Glucose News and Research

RSS

$Is prediabetes associated with increased fracture risk among midlife women?$

Is prediabetes associated with increased fracture risk among midlife women?

Studying the correlation between prediabetes before the menopause and increased fracture risk.

25 May 2023

New method of analysis flags a precursor to prediabetes

Scientists at Klick Labs have developed a new way to catch the earliest signs the human body is failing to control blood glucose levels, before it reaches prediabetic levels in patients.

25 May 2023

Digital plan of care leads to better outcomes of people living with type 2 diabetes, study shows

Research conducted as part of UKRIs digital health technology catalyst sponsored by Healum Ltd in partnership with Vernova Healthcare CIC, demonstrates that the use of Healum’s mobile app, connected to its care planning software and patient management system for healthcare professionals in primary care, has helped to improve health outcomes, health engagement and quality of life for people living with type 2 diabetes.

25 May 2023

Study maps cellular responses to blood sugar

Researchers at The University of Texas at El Paso have successfully mapped specific regions in the brain that are activated in association with changes in blood sugar - also known as glucose - providing fundamental location information that could ultimately lead to more targeted therapies for people who struggle with conditions like diabetes.

25 May 2023

Investigating the interplay between white blood cell count and incidence of hyper-low-density lipoprotein cholesterolemia

Researchers investigating the association between white blood cell count and LDL hypercholesteremia.

24 May 2023

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.

24 May 2023

Looking at cancer drugs to help put the brakes on classic indicators of aging

Antiretroviral cocktails can make human immunodeficiency virus, or HIV, undetectable and untransmittable, but both the virus and its treatment can also accelerate aging of bone and muscle.

24 May 2023

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas - a wearable, pocket-sized, automated insulin delivery device - that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year.

23 May 2023

Scientists unveil a metabolic Achilles' heel in pancreatic cancer

Research unveils the significance of uridine as a metabolic fuel in pancreatic ductal adenocarcinoma (PDA) cells under glucose-deprived conditions. Uridine utilization, mediated by uridine phosphorylase 1 (UPP1), supports redox balance, survival, and proliferation in PDA, highlighting its potential as a novel therapeutic target in the treatment of this resistant cancer.

23 May 2023

Metabolic sensors may play a role in the development of Alzheimer's disease, study suggests

It's well-known that people with Type 2 diabetes are at an increased risk of developing Alzheimer's disease, but the reason why isn't fully understood and is an area of current research.

22 May 2023

Surviving without glucose: uridine-derived ribose as an alternative energy source

Researchers attempted to identify new genes and molecular pathways that might supply energy when the availability of glucose or other nutrients is limited.

22 May 2023

Study could help understand why limiting sugary foods can ease symptoms for IBD patients

Excess sugar hampers cells that renew the colon's lining in a mouse model of inflammatory bowel disease (IBD), according to a new study by University of Pittsburgh scientists.

22 May 2023

Remote pulmonary artery pressure monitoring improves quality of life, reduces heart failure hospitalizations

The first investigator-initiated study of remote pulmonary artery pressure monitoring has found that it improves quality of life and reduces heart failure hospitalizations in patients with chronic heart failure.

22 May 2023

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

New research presented at this year's European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use.

22 May 2023

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study.

22 May 2023

Indirect inhibitors of cellular respiration for treatment of glioblastoma

A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Targeting cellular respiration as a therapeutic strategy in glioblastoma."

19 May 2023

Tirzepatide improves body composition across a range of adult age groups, study shows

A new analysis of SURMOUNT-1, the first Phase 3 study of tirzepatide in adults for chronic weight management shows that tirzepatide improves body composition across a range of adult age groups.

19 May 2023

Whole body cryostimulation: Useful "add-on" treatment for obesity

Whole body cryostimulation is a useful "add-on" treatment for obesity, research being presented at the European Congress on Obesity (ECO) in Dublin, Ireland (17-20 May) suggests.

19 May 2023

Are higher blood pressure, glucose, and low-density lipoprotein cholesterol in stroke survivors associated with cognitive decline?

The study assessed whether high blood pressure, glucose, and low-density lipoprotein cholesterol accelerated their cognitive decline.

19 May 2023

Glucose News and Research

Is prediabetes associated with increased fracture risk among midlife women?

New method of analysis flags a precursor to prediabetes

Digital plan of care leads to better outcomes of people living with type 2 diabetes, study shows

Study maps cellular responses to blood sugar

Investigating the interplay between white blood cell count and incidence of hyper-low-density lipoprotein cholesterolemia

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Looking at cancer drugs to help put the brakes on classic indicators of aging

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

Advances in automated insulin delivery systems reduce disease management burden for patients with diabetes

Scientists unveil a metabolic Achilles' heel in pancreatic cancer

Metabolic sensors may play a role in the development of Alzheimer's disease, study suggests

Surviving without glucose: uridine-derived ribose as an alternative energy source

Study could help understand why limiting sugary foods can ease symptoms for IBD patients

Remote pulmonary artery pressure monitoring improves quality of life, reduces heart failure hospitalizations

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

Indirect inhibitors of cellular respiration for treatment of glioblastoma

Tirzepatide improves body composition across a range of adult age groups, study shows

Whole body cryostimulation: Useful "add-on" treatment for obesity

Are higher blood pressure, glucose, and low-density lipoprotein cholesterol in stroke survivors associated with cognitive decline?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News